keyword
https://read.qxmd.com/read/38789364/hailey-hailey-disease-clinical-diagnostic-and-therapeutic-update
#1
JOURNAL ARTICLE
Adriana Maria Porro, Camila Arai Seque, Denise Miyamoto, Diego Vanderlei Medeiros da Nóbrega, Milvia Maria Simões E Silva Enokihara, Claudia Giuli Santi
Hailey-Hailey disease is a rare genodermatosis described in 1939, with an autosomal dominant inheritance pattern, characterized by compromised adhesion between epidermal keratinocytes. It has an estimated prevalence of 1/50,000, with no gender or race predilection. It results from a heterozygous mutation in the ATP2C1 gene, which encodes the transmembrane protein hSPA1C, present in all tissues, with preferential expression in keratinocytes. Mutations in the ATP2C1 gene cause changes in the synthesis of junctional proteins, leading to acantholysis...
May 23, 2024: Anais Brasileiros de Dermatologia
https://read.qxmd.com/read/38789085/long-term-effects-of-botulinum-toxin-a-versus-incisional-surgery-for-management-of-partially-accommodative-esotropia-in-children-comparison-of-three-approaches
#2
JOURNAL ARTICLE
Ying Wang, Jingjing Jiang, Li Li
PURPOSE: To compare the effect of bilateral medial rectus injection of botulinum toxin A (BTX-A), bilateral medial rectus muscle recession surgery (BMR rc), or unilateral medial rectus muscle recession combined with lateral rectus muscle resection surgery (R&R), in the management of partially accommodative esotropia (PAET) in children. DESIGN: Retrospective comparative clinical study. METHODS: The study cohort included 98 patients diagnosed with PAET who had BTX-A injection or incisional surgery between December 2014 and January 2023...
May 22, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38787406/systematic-review-of-the-utilization-of-botulinum-toxin-in-mohs-micrographic-surgery
#3
REVIEW
Sima Amin, Meagan M Olivet, Bradley Thigpen, Preetha Kamath, Conway Huang, Daniel Bergman
The use of botulinum toxin for off-label indications has become more prevalent, but the specific benefits in Mohs micrographic surgery (MMS) have not yet been fully elucidated. A systematic review was performed of PubMed, Cochrane, EMBASE, and Scopus databases to identify all articles describing the use of botulinum toxin in MMS. Analysis was subdivided into scar minimization, parotid injury, and pain management. A total of nine articles were included. Scar minimization and treatment of parotid injury were the most reported uses...
May 24, 2024: Archives of Dermatological Research
https://read.qxmd.com/read/38787080/botulinum-toxin-for-axial-postural-abnormalities-in-parkinson-s-disease-a-systematic-review
#4
REVIEW
Marialuisa Gandolfi, Carlo Alberto Artusi, Gabriele Imbalzano, Serena Camozzi, Mauro Crestani, Leonardo Lopiano, Michele Tinazzi, Christian Geroin
Axial postural abnormalities (APAs), characterized by their frequency, disabling nature, and resistance to pharmacological treatments, significantly impact Parkinson's disease and atypical Parkinsonism patients. Despite advancements in diagnosing, assessing, and understanding their pathophysiology, managing these complications remains a significant challenge. Often underestimated by healthcare professionals, these disturbances can exacerbate disability. This systematic review assesses botulinum toxin treatments' effectiveness, alone and with rehabilitation, in addressing APAs in Parkinson's disease, utilizing MEDLINE (PubMed), Web of Science, and SCOPUS databases for source material...
May 15, 2024: Toxins
https://read.qxmd.com/read/38787077/intramuscular-botulinum-neurotoxin-serotypes-e-and-a-elicit-distinct-effects-on-snap25-protein-fragments-muscular-histology-spread-and-neuronal-transport-an-integrated-histology-based-study-in-the-rat
#5
JOURNAL ARTICLE
Vincent Martin, Denis Carre, Heloise Bilbault, Sebastien Oster, Lorenzo Limana, Florian Sebal, Christine Favre-Guilmard, Mikhail Kalinichev, Christian Leveque, Virginie Boulifard, Catherine George, Stephane Lezmi
Botulinum neurotoxins E (BoNT/E) and A (BoNT/A) act by cleaving Synaptosome-Associated Protein 25 (SNAP25) at two different C-terminal sites, but they display very distinct durations of action, BoNT/E being short acting and BoNT/A long acting. We investigated the duration of action, spread and neuronal transport of BoNT/E (6.5 ng/kg) and BoNT/A (125 pg/kg) after single intramuscular administrations of high equivalent efficacious doses, in rats, over a 30- or 75-day periods, respectively. To achieve this, we used (i) digit abduction score assay, (ii) immunohistochemistry for SNAP25 (N-ter part; SNAP25N-ter and C-ter part; SNAP25C-ter ) and its cleavage sites (cleaved SNAP25; c-SNAP25E and c-SNAP25A ) and (iii) muscular changes in histopathology evaluation...
May 12, 2024: Toxins
https://read.qxmd.com/read/38787073/effectiveness-and-safety-of-onabotulinumtoxina-in-adolescent-patients-with-chronic-migraine
#6
JOURNAL ARTICLE
Laura Gómez-Dabó, Edoardo Caronna, Rut Mas-de-Les-Valls, Víctor J Gallardo, Alicia Alpuente, Marta Torres-Ferrus, Patricia Pozo-Rosich
Chronic migraine (CM) significantly affects underage individuals. The study objectives are (1) to analyze the effectiveness and safety of onabotulinumtoxinA (BTX-A) in adolescents with CM; (2) to review the literature on BTX-A use in the pediatric population. This prospective observational study included patients under 18 years old with CM treated with BTX-A (PREEMPT protocol) as compassionate use. Demographic, efficacy (monthly headache days-MHD; monthly migraine days-MMD; acute medication days/month-AMDM) and side effect data were collected...
May 11, 2024: Toxins
https://read.qxmd.com/read/38787072/therapeutic-uses-and-efficacy-of-botulinum-toxin-in-orofacial-medicine-a-dental-perspective
#7
EDITORIAL
Kazuya Yoshida, Merete Bakke
Botulinum neurotoxin (BoNT) is the exotoxin of Clostridium botulinum , a Gram-positive, spore-forming bacterium [...].
May 10, 2024: Toxins
https://read.qxmd.com/read/38787068/mindfulness-in-facilitating-pelvic-floor-botulinum-toxin-injection-in-women-with-chronic-pelvic-pain
#8
JOURNAL ARTICLE
Jacqueline V Aredo, Hannah K Tandon, Samin Panahi, Vy T Phan, Rezvan Ameli, Barbara I Karp, Pamela Stratton
Botulinum toxin (BoNT) injection can safely be done as an office-based procedure, but can be painful itself, especially when injecting pelvic floor muscles to treat chronic pelvic pain (CPP). Mindfulness interventions may reduce procedure-associated acute anxiety and pain. We applied mindfulness techniques to increase the tolerability of office-based pelvic floor BoNT injections in women with CPP. Women enrolled in a clinical trial of BoNT for endometriosis-associated CPP were offered a brief, guided mindfulness session before and/or after transvaginal injection...
May 9, 2024: Toxins
https://read.qxmd.com/read/38787055/beyond-pain-the-effects-of-onabotulinumtoxina-therapy-on-sensitization-and-interictal-symptoms-in-chronic-migraine
#9
REVIEW
Paolo Alonge, Filippo Brighina, Simona Maccora, Laura Pilati, Salvatore Di Marco, Davide Ventimiglia, Bruna Maggio, Ivana Cutrò, Cecilia Camarda, Angelo Torrente
Chronic migraine is a disease with a high burden on patients from both a working and quality of life point of view. The pathophysiology of this subtype of migraine is due to several factors, such as medication overuse. Nevertheless, the detrimental recurring of headache attacks with central and peripheral sensitization plays a central role and explains some additional symptoms complained about by these patients even in the interictal phase. OnabotulinumtoxinA is a therapy indicated for chronic migraine since it has proven to reduce peripheral sensitization, showing even efficacy on central symptoms...
April 23, 2024: Toxins
https://read.qxmd.com/read/38785278/cask-pathogenic-variant-which-expands-the-clinical-spectrum-for-micpch-syndrome-in-an-adult-patient
#10
Jack Tellerday, Jennifer Black, Donald C Schuessler, Nienke P Dosa, Wendy Alcaraz, Robert Roger Lebel
The CASK gene and its product protein kinase have been associated with microcephaly with pontine and cerebellar hypoplasia (MICPCH) syndrome and various other neurodevelopmental disorders. Clinical presentation is highly variable and generally includes intellectual disability, neurological disorders, and dysmorphic features, at a minimum. We present the case of one of the oldest known currently living patients with MICPCH syndrome with additional features not previously described in the literature (midface retrusion, macroglossia, dental crowding, adolescent-onset contractures at large joints, laxity at finger joints, and prominent wrist dystonia)...
May 24, 2024: American Journal of Medical Genetics. Part A
https://read.qxmd.com/read/38783620/-nonpharmacologic-treatment-of-chronic-constipation
#11
REVIEW
Myeongsook Seo, June Hwa Bae
Functional constipation is a common clinical diagnosis that affects approximately 14% of the world's population. Non-pharmacological therapies often represent the initial steps in management and may include lifestyle adjustments or changes such as physical activity and diet. Pharmacological options have been used when the non-pharmacological approach has been ineffective. Biofeedback therapy, surgery, sacral nerve stimulation, botulinum toxin injection, and vibrating capsules can be considered in scenarios where the laxatives are ineffective...
May 25, 2024: Korean Journal of Gastroenterology, Taehan Sohwagi Hakhoe Chi
https://read.qxmd.com/read/38782121/neurobiological-mechanisms-of-botulinum-neurotoxin-induced-analgesia-for-neuropathic-pain
#12
REVIEW
Ana Bagues, Jiaxin Hu, Ishraq Alshanqiti, Man-Kyo Chung
Botulinum neurotoxins (BoNTs) are a family of neurotoxins produced by Clostridia and other bacteria that induce botulism. BoNTs are internalized into nerve terminals at the site of injection and cleave soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins to inhibit the vesicular release of neurotransmitters. BoNTs have been approved for multiple therapeutic applications, including the treatment of migraines. They have also shown efficacies for treating neuropathic pain, such as diabetic neuropathy, and postherpetic and trigeminal neuralgia...
May 21, 2024: Pharmacology & Therapeutics
https://read.qxmd.com/read/38779725/decompression-surgery-in-elderly-patients-with-hemifacial-spasm-refractory-to-botulinum-toxin
#13
JOURNAL ARTICLE
Margaret Tugend, Christina M Ulane, Kevin Patel, Raymond F Sekula
BACKGROUND: Botulinum toxin is an effective treatment for hemifacial spasm in elderly patients. However, some patients do not tolerate the side effects and frequency of botulinum toxin treatments. OBJECTIVES: The purpose of this study was to evaluate the characteristics and outcomes of a cohort of elderly patients referred by neurologists for surgical decompression of the facial nerve following botulinum toxin treatment. METHODS: In a prospective cohort study, logistic regression was used to detect potential predictors of spasm-freedom after surgical decompression of the facial nerve in elderly patients that received ≤8 and >8 botulinum toxin treatments for hemifacial spasm before surgery...
May 23, 2024: Movement Disorders Clinical Practice
https://read.qxmd.com/read/38779676/isolation-and-characterization-of-hc-targeting-chimeric-heavy-chain-antibodies-neutralizing-botulinum-neurotoxin-type-b
#14
JOURNAL ARTICLE
Yujia Jiang, Rong Wang, Jiazheng Guo, Kexuan Cheng, Lei Chen, Xi Wang, Yating Li, Peng Du, Chen Gao, Jiansheng Lu, Yunzhou Yu, Zhixin Yang
BACKGROUND: Botulinum neurotoxin (BoNT) produced by Clostridium botulinum is one of the most potent known toxins. Moreover, BoNT is classified as one of the most important biological warfare agents that threatens the biosafety of the world. Currently, the approved treatment for botulism in humans is the use of polyvalent horse serum antitoxins. However, they are greatly limited because of insufficient supply and adverse reactions. Thus, treatment of human botulism requires the development of effective toxin-neutralizing antibodies...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38779375/the-role-of-neurotoxins-and-fillers-in-affirmative-care-in-gender-nonconforming-filipino-patients
#15
JOURNAL ARTICLE
Jonathan Nevin Yu, Camille Angeles, Hester Bueser, Antonio Sison
OBJECTIVE: Gender nonconformity refers to individuals whose gender identity, roles, or expressions do not adhere to societal standards and norms. Affirmative care is an approach to healthcare delivery in which organizations, programs, and providers recognize, validate, and support the identity stated or expressed by the individuals served. This study examined the effects of nonsurgical interventions performed by dermatologists, specifically botulinum toxins (BoNTA) and dermal filler injections, on the physical and mental health of Filipino gender nonconforming individuals...
May 2024: Journal of Clinical and Aesthetic Dermatology
https://read.qxmd.com/read/38768418/underreporting-or-failed-notification-global-botulism-reporting-2000-2022
#16
JOURNAL ARTICLE
Tristan P Learoyd
Botulism is a rare, potentially fatal illness caused by botulinum toxins produced by Clostridium bacteria. There are no coordinated worldwide reporting mechanisms for botulism cases and therefore few reliable case frequency estimates. This study aimed to establish an international benchmark for case frequency to determine estimated global rates of underreporting of botulism cases. To this end, a comprehensive, multilingual search of major global and national databases, including gray data and government sources, was performed...
May 20, 2024: Health Security
https://read.qxmd.com/read/38767308/botulinum-toxin-in-the-rehabilitation-of-painful-syndromes-multiperspective-literature-analysis-lexical-analysis-and-systematic-review-of-randomized-controlled-trials
#17
JOURNAL ARTICLE
Daniele Coraci, Maria Chiara Maccarone, Lisa Ragazzo, Lucrezia Tognolo, Domenico Antonio Restivo, Gabriele Santilli, Ana Lucila Moreira, Paola Emilia Ferrara, Gianpaolo Ronconi, Stefano Masiero
Pain represents a common symptom of several diseases and is often associated with a reduction in rehabilitation outcomes and recovery. The effectiveness of pain alleviation by botulinum toxin has been recently demonstrated. We searched in PubMed the papers about this topic published in the last ten years, and we selected clinical trials, guidelines, meta-analyses, reviews, and systematic reviews. We used different approaches: multiperspective presentation, lexical evaluation, and systematic review. The systematic review was only performed for the randomized controlled trials...
May 20, 2024: European Journal of Translational Myology
https://read.qxmd.com/read/38760282/french-guidelines-for-the-diagnosis-and-management-of-tourette-syndrome
#18
A Hartmann, S Ansquer, C Brefel-Courbon, P Burbaud, A Castrioto, V Czernecki, P Damier, E Deniau, S Drapier, I Jalenques, O Marechal, T Priou, M Spodenkiewicz, S Thobois, A Roubertie, T Witjas, M Anheim
The term "Gilles de la Tourette syndrome", or the more commonly used term "Tourette syndrome" (TS) refers to the association of motor and phonic tics which evolve in a context of variable but frequent psychiatric comorbidity. The syndrome is characterized by the association of several motor tics and at least one phonic tic that have no identifiable cause, are present for at least one year and appear before the age of 18. The presence of coprolalia is not necessary to establish or rule out the diagnosis, as it is present in only 10% of cases...
May 16, 2024: Revue Neurologique
https://read.qxmd.com/read/38758415/a-systematic-review-of-the-perspectives-of-botulinum-toxin-use-on-the-quality-of-life-of-neurological-patients-with-drooling
#19
REVIEW
Michelle Almeida Silva, Márcia Maria Fonseca da Silveira, Bruna Rafaele Vieira Pedrosa, Rebeka Thiara Nascimento Thiara Dos Santos, Zilda Betânia Barbosa Medeiros de Farias, Ana Paula Veras Sobral
OBJECTIVE: To investigate the effectiveness of botulinum toxin in the salivary glands of patients with neurological impairment and drooling and its impact on the quality of life. MATERIALS AND METHODS: This systematic review was registered with the International Prospective Register of Systematic Reviews (CRD 42,023,435,242) and conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses. An electronic search was performed in the PubMed/MEDLINE, Embase, Scopus, Cochrane Library, and clinical trial databases until August 2023, no language restriction...
May 17, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38758085/ultrasound-guided-lidocaine-injection-as-a-novel-predictor-of-response-to-botulinum-for-patients-with-myofascial-pain-syndrome-a-case-report
#20
JOURNAL ARTICLE
Olivia A Agee, Jeffery C Leggit
Botulinum injection is a well-known non-surgical intervention utilized in the management of myofascial pain syndrome (MPS). However, sparse evidence exists regarding the utility of ultrasound guidance of injectate or lidocaine as a predictive marker of patient response to botulinum toxin A (BTX-A). A 39-year-old male active duty service member demonstrated typical signs and symptoms of MPS. He reported a 10-year history of neck and back spasms that were triggered by exertion but also could occur spontaneously...
May 17, 2024: Military Medicine
keyword
keyword
31158
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.